MedTrace Logo

Auricular Muscle Zone Stimulation for Parkinson Disease

NCT04652583 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2022-01-11

No results posted yet for this study

Summary

A Multicenter, Randomized, Blinded, Electronic Device in Subjects with Parkison Disease.

Conditions

  • Parkinson Disease

Interventions

DEVICE

Earstim - Active Stimulation

Intramuscular stimulation

DEVICE

Earstim - Sham Stimulation

Sham stimulation

Sponsors & Collaborators

  • The Parkinson Study Group

    collaborator NETWORK

  • Stoparkinson Healthcare Systems LLC

    lead INDUSTRY

Principal Investigators

  • Yusuf O Cakmak, MD, PhD · Stoparkinson Healthcare Systems LLC

  • Stanley Fahn, MD · H. Houston Merritt Professor of Neurology, Columbia University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2022-01-05
Completion
2022-01-05
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04652583 on ClinicalTrials.gov